US 8299099
Heteroaryl derivatives as CFTR modulators
granted A61KA61K31/443A61K31/497
Quick answer
US patent 8299099 (Heteroaryl derivatives as CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/443, A61K31/497, A61K31/501, A61K31/506